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Background
Cardiac dysfunction is often associated with a shift in
substrate preference and metabolism, but current in vivo
techniques only provide information on substrate
uptake. Hyperpolarized (HP) MR has the unique ability
to detect metabolism in vivo and is highly specific. To
evaluate the prospects for measuring myocardial sub-
strate selection in vivo, HP [1-13C]pyruvate and [1-13C]
butyrate were co-infused into rats.
Methods
Pyruvate and butyrate were hyperpolarized by DNP.
After dissolution the samples were automatically infused
into fed or fasted animals. Myocardial metabolism was
detected using a train of cardiac triggered 30o adiabatic
inspection pulses applied every 3 s at 9.4T with 1H
decoupling. Metabolite ratios were calculated to assess
overall consumption of the imaging agents.
Results
Downstream metabolites of butyrate including ketone
bodies b-hydroxybutyrate (BHB) and acetoacetate, acetyl-
carnitine, butyrylcarnitine, citrate, and glutamate, were
observed in vivo and affected by fasting (1A) and co-infu-
sion of pyruvate (1B). Pyruvate competed with butyrate
for the production of acetyl-CoA as evidenced by changes
in the production of bicarbonate (2C), acetylcarnitine
(1D,2E), glutamate (1E,1G) and acetoacetate (1C,1F).
Fed state
Mitochondrial pseudoketogenesis facilitated the labeling
of the ketone bodies, and no evidence of true ketogenesis
was observed. The competition presented by butyrate
results in a decrease in the bicarbonate signal (2C, 2G).
From the perspective of butyrate metabolism, the gluta-
mate (1E, 1G) decreased and the appearance of acetoace-
tate (1C, 1F) was nearly quenched. The acetylcarnitine
increase (1D) and decrease in glutamate and acetoacetate
signals were modulations due to competition from pyru-
vate for the limited number of free CoA units in the
mitochondria, and the antiporting of acetoacetate when
pyruvate enters the mitochondria.
Fasted state
Different enzyme expressions and circulating substrates in
the fasted myocardium reduced PDH flux (2C) and
increased lactate, interpreted as a redox state increase.
Glutamate was lower (1E, 1G) while pool sizes remain
unchanged, indicating decreased 13C labeling. An increase
in acetoacetate was observed (1C, 1F). With increased cir-
culating ketones, label exchange into acetoacetate is facili-
tated, decreasing the fraction of label available for
production of acetylCoA and glutamate. Acetylcarnitine
(2E) rose and a drop in bicarbonate (2C, 2G) was observed.
The change in glutamate to acetylcarnitine ratio decreased
significantly upon introduction of pyruvate (1G).
Conclusions
Pyruvate and butyrate competed for the production of
acetyl-CoA and fasting produced logical changes in the
observed spectra. Co-infusion of HP metabolic fuels is a
one of a kind method for assessing myocardial substrate
preference in vivo. The combination of HP 13C technology
and co-administration of two separate imaging agents
enables noninvasive and simultaneous monitoring of both
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Figure 1 (A) In vivo cardiac 13C spectrum recorded after the injection and metabolism of hyperpolarized [1-13C]butyrate in the fed and fasted
state (n=6 in both groups). (B) A sum spectrum with expansion to show the downstream metabolites of the co-injection experiments with both
HP butyrate and pyruvate (n=7 in both groups). (C-E) The normalized signals relative to the injected substrate [1-13C]butyrate associated with
metabolites of [1-13C]butyrate in the 4 experimental conditions. (F & G) Relative ratios of acetoacetate and glutamate to that of acetylcarnitine.
The signals of glutamate and acetoacetate demonstrate the competition between pyruvate and butyrate for the production of acetyl-CoA as well
as the impact of pyruvate on pseudoketogenesis. (&) Two way ANOVA reports a significant overall effect of the factor of nutritional state on the
ratios of acetoacetate to butyrate and glutamate to butyrate. Error bars indicate +/- SEM.
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Figure 2 (A) In vivo cardiac 13C spectrum recorded after the injection and metabolism of hyperpolarized [1-13C]pyruvate in the fed state (n=5 in
both groups). Signal ratios of lactate (B, F), bicarbonate (C,G) and acetylcarnitine (E) relative to pyruvate and alanine in all 4 experimental groups
where hyperpolarized [1-13C]pyruvate was either injected separately or co-injected with hyperpolarized [1-13C]butyrate in both fed and fasted
animals. Note the nearly constant fraction of alanine, which justifies its use as normalization factor for the other metabolites as was shown
previously in perfused heart. Error bars indicate +/- SEM.
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